In a secondary analysis of 2467 women aged ≥65 in the Women's Health Initiative Memory Study hormone therapy trial (mean 18-year follow-up), lower Aβ42/40 and higher p-tau181, GFAP and NfL were associated with incident MCI/dementia; GFAP most strongly.
Secondary analysisn = 2,467
Mielke et al. Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy